NCT00465803

A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension

Compliance Study Comparing DuoTrav to TRAVATAN Plus Timolol Using the Dosing Aid

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 81 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess patient compliance with DuoTrav versus concomitant administration of Timolol 0.5% plus TRAVATAN in patients with open-angle glaucoma or ocular hypertension.

Conditions

• Open-angle Glaucoma
• Ocular Hypertension

Interventions

Type	Name	Description
DRUG	Travoprost 0.004%/timolol 0.5% ophthalmic solution	One drop in the study eye(s) once daily at either 8 AM or 8 PM for twelve months using the Dosing Aid
DRUG	Travoprost ophthalmic solution, 0.004%	One drop in the study eye(s) once daily at 8 PM for twelve months using the Dosing Aid
DRUG	Timolol maleate ophthalmic solution, 0.5%	One drop in the study eye(s) once daily at 8 AM or twelve months using the Dosing Aid

Timeline

• Start date: 2007-03-01
• Primary completion: 2009-01-01
• First posted: 2007-04-25
• Last updated: 2014-07-24

Locations

1 site across 1 country: United States